Clinical Trials Logo

Clinical Trial Summary

Prolonged corrected QT interval (QTc) has been observed in about half of patients with liver cirrhosis. Marked prolongation of QTc (ie, 500 msec) has been considered to be a risk factor for fatal ventricular arrhythmia, such as torsade de pointes,7,8 which has been reported in liver transplantation (LT) surgery. In a previous study, prolonged QTc interval ( 500 msec) was frequently observed throughout the procedure of LT, even among patients with baseline QTc 440 msec. Therefore, it is important to optimize electrolyte balance and hemodynamic status to reduce greater risk of perioperative arrhythmias. The investigators hypothesized that the change of QTc interval might be differ according to method of general anesthesia (inhalation agent vs. intravenous agent).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Liver Cirrhosis
  • Liver Cirrhosis(Who Will Undergo Planed Liver Transplantation)

NCT number NCT03864276
Study type Interventional
Source Yonsei University
Contact
Status Completed
Phase N/A
Start date February 17, 2019
Completion date December 31, 2020